Evozyne
Biotechnology ResearchIllinois, United States51-200 Employees
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs.
Insights
Gathering insights about Evozyne…
Similar companies to Evozyne
Carlsmed
$25M$50MC16 Biosciences
$10M$25MNotch Therapeutics
$1M$10MInsilico Medicine
$1B$10BLygos
$50M$100MProteinQure
$1M$10MAbsci
$1M$10MGRO Biosciences
$1MArzeda
$25M$50M
Evozyne Tech Stack
Evozyne uses 8 technology products and services including CUDA, ProcessWire, MySQL, and more. Explore Evozyne's tech stack below.
- CUDAAudio, Video, Graphics
- ProcessWireContent Management System
- MySQLDatabase
- gitDevelopment
- DropboxDigital Asset Management
- LinkedInOnline Community Software
- WP EnginePlatform As A Service
- PythonProgramming Languages
Media & News
Evozyne's Email Address Formats
Evozyne uses at least 1 format(s):
| Evozyne Email Formats | Percentage |
| First.Last@evozyne.com | 50% |
| First.Last@evozyne.com | 50% |
Frequently Asked Questions
What is Evozyne's official website and social media links?
Evozyne's official website is evozyne.com and has social profiles on LinkedInCrunchbase.What is Evozyne's SIC code NAICS code?
Evozyne's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Evozyne have currently?
As of January 2026, Evozyne has approximately 54 employees across 1 continents, including North America. Key team members include Chief Drug Discovery Officer: U. H.Senior Director Of Business Development: C. P.Project Manager Of Corporate Innovation: E. A.. Explore Evozyne's employee directory with LeadIQ.What technology does Evozyne use?
Evozyne's tech stack includes CUDAProcessWireMySQLgitDropboxLinkedInWP EnginePython. What is Evozyne's email format?
Evozyne's email format typically follows the pattern of First.Last@evozyne.com. Find more Evozyne email formats with LeadIQ. How much funding has Evozyne raised to date?
As of January 2026, Evozyne has raised $81M in funding. The last funding round occurred on Sep 27, 2023 for $81M.When was Evozyne founded?
Evozyne was founded in 2020.
Company Overview
- Website
- evozyne.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2020
- Employees
- 51-200
Media & News
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $25M$50M
Evozyne's revenue is estimated to be in the range of $25M$50M
Funding & Financials
- $81M
Evozyne has raised a total of $81M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $81M.
- $25M$50M
Evozyne's revenue is estimated to be in the range of $25M$50M
Company Leadership
U. H.Chief Drug Discovery Officer
C. P.Senior Director Of Business Development
E. A.Project Manager Of Corporate Innovation- K. P.Senior Data Scientist And Sustainability Lead
- D. M.Senior Information Technology Administrator
Employee Directory
- X. X.Research Scientist
- C. C.Business & Clinical Development Consultant
- R. L.Research Scientist
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
